// App-Quantinova.ai

TCT-156 : Impact of Clopidogrel Hyporesponsiveness on Clinical Outcomes in Patients Receiving Drug-eluting Stents for Stable Coronary Disease in the ADAPT-DES Study

Researchers

Presenter

  • Dietmar Trenk

Principal Investigators

  • Bruce R. Brodie

  • Heinz Joachim Buttner

  • David Cox

  • Peter L. Duffy

  • Timothy D. Henry

  • Ajay J. Kirtane

  • Ernest L. Mazzaferri

  • Roxana Mehran

  • D. Christopher Metzger

  • Gregg W. Stone

Medical Centers

  • Columbia University, New York, New York, United States

  • Columbia University / Cardiovascular Research Foundation, New York, NY

  • Lehigh Valley Health Network, Allentown, PA

  • Universitaets-Herzzentrum Freiburg Bad Krozingen, Bad Krozingen, Germany

  • Cardiovascular Research Foundation, Orangeburg, NY

  • LeBauer CV Research Foundation, Greensboro, NC

  • Pinehurst Cardiology, Pinehurst, NC

  • Universitaets-Herzzentrum Freiburg Bad Krozingen, Bad Krozingen, Germany

  • The Ohio State University, Dublin, OH

  • Lebauer Cardiovascular Research Foundation, Greensboro, United States

  • Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Minneapolis, MN

  • Charite Campus Benjamin Franklin, Berlin, Germany.

  • Mount Sinai Hospital, New York, NY

  • Wellmont Cancer Institute, Kingsport, TN

  • Cardiovascular Research Foundation, Orangeburg, NY

Locations

  • United States

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

  • Angina

Biomarkers

  • Amyloid P compound, Serum

Drug/Treatment

  • Clopidogrel bisulfate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved